Data as of Q4 2025 (Dec 31, 2025)

Hennion & Walsh Asset Management, Inc.

โ€ขCIK: 1861642โ€ขFiling: Q4 2025

**Hennion & Walsh Asset Management, Inc.** manages $2.9B across a diversified portfolio of 926 positions. The firm maintains significant exposure to core market indices and technology leaders, highlighted by top holdings including IVV at $117.3M and GSLC at $70.4M. Further allocations include substantial positions in GSIE ($55.2M), DDWM ($54.9M), and ISPY ($44.6M). This structure suggests a systematic, large-cap growth orientation within its investment mandate.

Total AUM
$2.9B
QoQ Performance
+5.0%
Positions
862
Top 10 Concentration
25.7%
Latest Filing
Q4 2025

Top Holdings Allocation

IVV4.0%
GSLC2.4%
GSIE1.9%
DDWM1.9%
ISPY1.5%
VTV1.5%
IGEB1.4%
RSP1.2%

๐Ÿ“ˆ Biggest Buys

NOW
SERVICENOW INC
+428.9%
0.3% of portfolio
OLMA
OLEMA PHARMACEUTICALS INC
+83.2%
0.4% of portfolio
VGM
INVESCO TR INVT GRADE MUNS
+1650.4%
0.2% of portfolio
NMZ
NUVEEN MUN HIGH INCOME OPPOR
+57.5%
0.4% of portfolio
MQY
BLACKROCK MUNIYILD QULT FD I
+35.1%
0.6% of portfolio

๐Ÿ“‰ Biggest Sells

6RJ0
ROCKET LAB CORP
-45.0%
0.2% of portfolio
VMO
INVESCO MUN OPPORTUNITY TR
-34.8%
0.2% of portfolio
NZF
NUVEEN MUNICIPAL CREDIT INC
-15.8%
0.6% of portfolio
MDGL
MADRIGAL PHARMACEUTICALS INC
-36.5%
0.2% of portfolio
STX
SEAGATE TECHNOLOGY HLDNGS PL
-36.5%
0.1% of portfolio

Sector Breakdown

Other74.5%
Technology9.3%
ETF6.0%
Financial3.0%
Healthcare2.3%
Consumer1.9%
Industrial1.4%
Utilities0.6%

๐Ÿšช Exited Positionssold since Q3 2025

VRNA
VERONA PHARMA PLC
SOLD
$19.8M
ZLAB
ZAI LAB LTD
SOLD
$5.4M
VKI
INVESCO ADVANTAGE MUN INCOME
SOLD
$5.3M
LEO
BNY MELLON STRATEGIC MUNS IN
SOLD
$4.9M
โ€”
KINIKSA PHARMACEUTICALS INTL
SOLD
$4.7M
+732 more exited positions

Changes from Q3 2025

โ†‘141 increased
โ†“59 decreased

Historical Filings

Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023